Skip to main content
Global Bioenergies logo

Global Bioenergies — Investor Relations & Filings

Ticker · ALGBE ISIN · FR0011052257 LEI · 969500H46XRAMTMVB676 PA Manufacturing
Open in API
Filings indexed 443 across all filing types
Latest filing 2016-10-28 Capital/Financing Update
Country FR France
Listing PA ALGBE

About Global Bioenergies

https://www.global-bioenergies.com/?lan…

Global Bioenergies develops and commercializes a process to convert renewable resources, such as plant-based sugars and agricultural waste, into isobutene. The company's proprietary technology utilizes fermentation and synthetic biology to produce this key hydrocarbon, which serves as a platform molecule for various applications. The bio-isobutene can be converted into ingredients for the cosmetics industry, specialty chemicals, and renewable fuels. A primary strategic focus is the production of Sustainable Aviation Fuel (SAF) to support the decarbonization of the aviation sector. The process provides a bio-based alternative to petroleum-derived hydrocarbons, aiming to reduce CO2 emissions and dependence on fossil fuels.

Recent filings

Filing Released Lang Actions
GLOBAL BIOENERGIES COMMUNIQUE DE PRESSE
Capital/Financing Update Classification · 99% confidence The document announces the effective implementation of a flexible bond financing arrangement ('financement obligataire flexible') involving the issuance of convertible bonds (OCA) and warrants (BSA) to the fund Bracknor Investment. It details the execution of the second tranche, referencing prior announcements and shareholder approval from an extraordinary general meeting. This content specifically relates to fundraising, capital structure changes, and debt instruments, which aligns directly with the definition of 'Capital/Financing Update'. It is not a full annual report (10-K), an earnings release (ER), or a simple announcement of a report (RPA).
2016-10-28 French
GLOBAL BIOENERGIES PRESS RELEASE
Regulatory Filings Classification · 86% confidence The document is a press release dated September 28, 2016, announcing a technical achievement: the first production of isobutene from wheat straw at an industrial pilot scale, resulting from a collaboration between Global Bioenergies and Clariant. It details the processes involved and includes quotes from management. This type of announcement, focusing on operational milestones, technological progress, and partnership updates, does not fit neatly into standard periodic financial reports (10-K, IR, ER) or specific corporate actions (DIV, CAP, DIRS). It is a general corporate announcement regarding business development and technology. Since it is not a standard regulatory filing like a 10-K or a specific financial report, and it is not explicitly an announcement of a report publication (RPA), the most appropriate general category for a significant, non-financial-period-specific corporate update that doesn't fit other specific codes is the general Regulatory Filings fallback category (RNS), as it serves as a broad communication to the market about a material development.
2016-09-28 English
GLOBAL BIOENERGIES COMMUNIQUE DE PRESSE
Regulatory Filings Classification · 94% confidence The document is a press release dated September 28, 2016, announcing a technical achievement: the first production of isobutene from wheat straw hydrolysate at an industrial pilot scale, involving Global Bioenergies and Clariant. It details the collaboration, the technology used (Clariant's sugar extraction and Global Bioenergies' fermentation), and includes quotes from management. This type of announcement, detailing a significant operational milestone or partnership outcome, is generally classified as a general Regulatory Filing (RNS) or potentially an Investor Presentation (IP) if it were structured as a slide deck. However, given the format (press release announcing a technical/operational success) and the lack of specific financial reporting elements (like 10-K, IR, ER, or DIV), the most appropriate general category for a significant, non-standard announcement is Regulatory Filings (RNS), as it serves as a broad communication to the market about company progress. It is not a formal financial report, management discussion, or board change. Since it is a detailed announcement rather than a brief notice stating a report is attached, it is not RPA.
2016-09-28 French
PRESS RELEASE
Regulatory Filings Classification · 85% confidence The document is a press release dated September 26, 2016, announcing a collaboration between four companies (GLOBAL BIOENERGIES, PREEM, SEKAB, and SVEASKOG) to develop a bio-based gasoline project in Sweden, supported by the Swedish Energy Agency. It details the scope study, the technology involved (Isobutene process, CelluAPP®), and includes quotes from management. This type of announcement, detailing strategic partnerships, project development, and technological milestones, does not fit the specific definitions for financial reports (10-K, IR, ER), shareholder actions (AGM-R, DVA), or insider trading (DIRS). It is a general corporate announcement regarding a strategic business development. Since it is not a formal regulatory filing like a 10-K or a specific financial report, and it is not a simple announcement of a report publication (RPA), the most appropriate general category for a significant corporate development announcement that doesn't fit elsewhere is 'Regulatory Filings' (RNS) as a catch-all for non-standard corporate news, although 'LTR' (Legal Proceedings Report) or 'CAP' (Capital/Financing Update) are not applicable. Given the options, RNS serves as the best fit for a press release detailing a major operational/strategic collaboration that isn't explicitly covered by other codes.
2016-09-26 English
COMMUNIQUE DE PRESSE
Regulatory Filings Classification · 95% confidence The document is a press release dated September 26, 2016, announcing a collaboration agreement between GLOBAL BIOENERGIES and three Swedish companies (PREEM, SEKAB, SVEASKOG) to study the implementation of a bio-sourced gasoline plant in Sweden, supported by the Swedish Energy Agency. This is a strategic business announcement detailing a partnership and a conceptual study for a future project, not a mandatory regulatory filing like a 10-K, an earnings release (ER), or a formal capital/financing update (CAP). It describes management's strategic direction regarding technology adoption and partnerships. This type of announcement, detailing strategic business developments and collaborations, fits best under the general category of Investor Relations or a specific strategic update. Given the options, it is a general announcement that doesn't fit the highly specific categories like DIRS, DIV, or DEF 14A. It is not a formal report (like AR or IR) but a news release about a project. Since it details strategic direction and collaboration, it is closest to a general corporate announcement, which often falls under Regulatory Filings (RNS) if no better fit exists, or potentially a general Investor Relations document. However, since it is a press release announcing a strategic business development and partnership, and not a mandatory SEC filing, RNS (Regulatory Filings - general regulatory announcements and fallback) is the most appropriate general classification for non-standard corporate news releases.
2016-09-26 French
COMMUNIQUE DE PRESSE
Capital/Financing Update Classification · 99% confidence The document is a detailed announcement from Global Bioenergies regarding the signing of a contract for a flexible bond financing arrangement involving the issuance of convertible bonds with stock warrants (OCABSA) for a total nominal amount of 11.25 million euros. It discusses the objectives of the operation, the mechanics of the issuance (tranches, conversion formulas, exercise prices), potential shareholder dilution, and the need for shareholder approval for future tranches. This content clearly falls under the category of updates on company fundraising, financing activities, or capital structure changes. Therefore, the appropriate classification is 'Capital/Financing Update' (CAP). The document is substantial and describes the terms of the financing itself, not just announcing that a financing document is available, so it is not an RPA or RNS.
2016-09-23 French

Browse filings by year

13 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.